Description: The
book describes the mechanisms involved in the maintenance of neuroendocrine-immune
interactions in ageing. The lack of this maintenance leads to the appearance
of age-related diseases (cancer, infections, dementia) and subsequent disability.
The capacity of some hormones or nutritional factors in restoring and remodeling
the neuroendocrine-immune response during ageing is reported presenting
possible new anti-ageing strategies in order to reach healthy ageing and
longevity.
I.
Introduction. Evolutionary
aspects for the neuroendocrine immune network and ageing.
Rainer
H. Straub
II.
Ageing of the immune system
Immunosenescence.
Rafael
Solana, Graham Pawelec
Zinc-binding
proteins (metallothionein and alpha-2 macroglobulin) as potential biological
markers of immunosenescence.
Eugenio
Mocchegiani, Robertina.Giacconi , Elisa Muti , Mario Muzzioli and Catia
Cipriano
Neutrophil
ageing and immunosenescence.
Stephen
K.Butcher, Keging Wang , David Lascelles, and Janet M. Lord
Apoptosis
and ageing.
Anis
Larbi and Tamas Fulop
MHC-unrestricted
cytotoxicity in ageing.
Mauro
Provinciali, Alessia Donnini and Francesca Re
Major
histocompatibility complex polymorphisms and ageing.
Giuseppina
Candore , Calogero Caruso, Giuseppina Colonna-Romano and Domenico
III.
Ageing of the endocrine system
Neuroplascticity
in the human hypothalamus during ageing.
Michel
A. Hofman and Dick F. Swaab .
The
role of growth hormone signalling in the control of ageing.
A.
Bartke, M. Heiman, D.Turyn, F.Dominici and J.J.Kopchick
Ageing
and the adrenal cortex.
Valeria
Lamounier-Zepter and Stefan R. Bornstein
Hormonal
changes in ageing men.
Eugen
Plas, Stephan Madersbacher and P. Berger
Ageing
and the endocrine circadian system.
Yvan
Touitou and Erhard Haus
Melatonin
rhythms, melatonin supplementation and sleep in old age.
Rixt
F. Riemersma, Caroline A.M. Mattheij, Dick F.Swaab and Eus J.W.Van Someren
IV.
Ageing of the nervous system
Age-related
changes of the human autonomic nervous system.
Marcus
W. Agelink, Dirk Sanner and Dan Ziegler
Age-related
alterations in autonomic nervous innervation.
Denise
L. Bellinger, Kelly S. Madden and Dianne Lorton .
Ageing
and the neuroendocrine system of the gut.
Magdy
El-Salhy
Modulating
effects of nutrition on brain ageing.
Carlo
Bertoni-Freddari , Patrizia Fattoretti, Tiziana Casoli,Giuseppina Di Stefano,
Moreno Solazzi, Belinda Giorgetti and Marta Balietti
Ageing-related
role of nitric oxide in the brain.
Stefano
Mariotto, Massimo Miscusi, Tizianna Persichini, Marco Colasanti and Hisanori
Suzuki
V.
Links between one global system and another global system during the ageing
process
Introduction
Rainer
H. Straub
Pasticity
of neuroendocrine-thymus interactions during ontogeny and ageing: Role
of zinc.
Eugenio
Mocchegiani, Robertina Giacconi , Elisa Muti , Mario Muzzioli and Catia
Cipriano
Adverse
glucocorticoid actions and their relevance to brain ageing.
Klaus
Dinkel and Robert M. Sapolsky
Neuroendocrine
- immune aspects of osteoporosis during the ageing process.
Meinrad
Peterlik
VI.
The ageing process and chronic inflammatory diseases
Neuroendocrine
immune mechanisms of accelerated ageing in patients with chronic inflammatory
diseases.
Rainer
H. Straub, Jürgen Schölmerich and Maurizio Cutolo
Thyroid
autoimmunity and ageing.
Stefano
Mariotti, Giovanni Pinna and Aldo Pinchera
The
clinical importance of proinflammatory cytokines in elderly populations.
Helle
Bruunsgaard and Karen Krabbe
VII.
Conclusions
Possible
new anti-ageing strategies related to neuroendocrine immune interactions.
Eugenio
Mocchegiani and Rainer H. Straub
Concluding
remarks and future directions.
Istvan
Berczi and Andor Szentivanyi
Concluding
Remarks and Future Directions
ISTVAN
BERCZI1 and ANDOR
SZENTIVANYI2
1
Department of Immunology, Faculty of Medicine, The University of Manitoba,
Winnipeg, MB Canada, R3E 0W3, and 2Department
of Internal Medicine, Faculty of Medicine, The University of South Florida,
Tampa, Florida 33612, USA
ABSTRACT
It
is indicated by this volume that normal age related changes in the neuroimmune
regulatory network are highly relevant to “successful”, or healthy ageing.
Abnormal regulation is associated with age related diseases. Clinical observations
provide compelling evidence for the relevance of Neuroimmune Biolgy (NIB)
to practical Medicine. Thus the Science of NIB provides novel perspectives
for the investigation of highly complex biological processes, such as ageing
and lead to original observations that allows for better understanding
of higher organisms in their entire complexity. The future is very challenging
both scientifically and from the moral standpoint.
1.
INRODUCTION
Ageing
is one of the unresolved problems in Biology. However, the rule is abundantly
clear: we all must be born in order to exist and eventually must die. Without
this iron-fisted law of Mother Nature the evolution of the species would
have been difficult if not impossible. Further, the proper balance of the
Plant and Animal Kingdoms would have been endangered. Clearly, immortality
could be considered as the cancer of the evolutionary process and of normal
biological ecosystems.
By
now it is firmly established that programmed cell death (apoptosis) is
part of normal embryonic and post-partum development as well as it is fundamental
to the regulation of various systems in the body, including the immune
system. Immune killer cells use apoptosis as efficient weapons for the
elimination of infected and cancerous target cells. Clearly all of our
cells possess the genetic machinery for apoptosis and there are multiple
receptors that are capable of committing various somatic cells to the suicide
pathway [1-3]. One may pose the question: if all of our cells can be induced
to die, are we also programmed to die? Common sense would give us
a Yes answer. In other words, under normal conditions ageing may be a maturation
process, which will proceed smoothly, without major life-threatening problems.
This is often termed as “successful” ageing. However, it seems that in
most people ageing is associated with major abnormalities, including of
those of the Neuroimmune Regulatory System and consequently, diseases prevail
during aging. The chapters in this book lend support to this hypothesis.
2.
AGING OF THE IMMUNE SYSTEM
2.1
Immunosenescence.
The
currently accepted wisdom is that as we age, we get sicker and sicker,
and then we die. Early immunological studies support very well this common
belief. Nearly all immune parameters have been shown to decline with ageing,
especially when male subjects were examined. However, most clinical experiments
are done in hospitals, where only sick people are available for study.
Some recent data indicate that healthy old people have healthy immune -,
endocrine - and nervous systems. Nevertheless, the Immune System shows
age-related changes, but it may be regarded as maturation, rather then
a disastrous break down. Thus thymus involution is possible because
the thymus has less and less work to do with our immunological adaptation
to our external and internal environment. This hypothesis is supported
by the fact that antigen presentation does not decline, if anything it
is improving with age. So are memory T lymphocytes. Few immunological phenomena
carry the same significance than antigen presentation and immunological
memory [4-6].
The
above parameters are fundamental pre-requisites of maintaining an effective
immune defense. So, if older people are better than in some aspects of
immunity than are younger individuals, should they be examined with the
expectation that they are deficient? Should not we consider the possibility
that a process of immune maturation takes place during aging that under
normal conditions is capable of maintaining good health and survival? Should
one consider the possibility of ripen old age without disease? Studies
of healthy old people in order to learn more about health, disease, the
immune system and ageing represent a new dimension of research in ageing
[7-9]
Apparently
now there is evidence for the relationship between the oligoclonal expansion
of lymphocytes with age and endogenous viruses (e.g. Herpes, Cytomegalovirus
and Epstein-Barr virus) [10-13].
Traditionally
these viruses are viewed as potential pathogens, rather than anything else.
However, it is possible to envision a different perspective for these persistent
organisms. It is clear that they become activated from time-to-time and
in immunodeficient individuals they may even cause disease and death. But
during temporary deficiency they actually may serve as powerful and relatively
harmless immunological adjuvants that activate the cytokine system, which
has enormous restorative and stimulatory power for the immune system. For
instance, EBV is a polyclonal B cell activator. Therefore, it relevant
to boosting (natural) antibody mediated defense. Herpes and CMV would be
relevant to boosting the T cell and NK cell-mediated immunity by the stimulation
of the right cytokines, such as interferons. Indeed the maintenance of
persistent viruses may be symbiotic, rather than antagonistic to the organism.
An analogous situation exists with LPS, which is released by intestinal
bacteria and will absorb and boost the immune system during emergency situations,
such as trauma and shock [14,15] The boosting of host defense mechanisms
with the aid of symbiotic microorganisms is likely to acquire more and
more significance during the ageing process. This is a very effective way
of self-medication. Clearly, the biological significance of persistent
viruses need further clarification .
2.2
Metallothioneins as potential biological markers of immunosenescence.
The
zinc-zinc-binding protein system regulates the activity of key hormones,
cytokines and enzymes in the body. Moreover, this system is affected by
stress and the zinc binding proteins are known as acute phase proteins
(APP). Apparently Zn is essential for the normal function of the adaptive
immune system as it controls the activity of key hormones, such as growth
hormone (GH) and of cytokines, as well as enzymes. Indeed, the over-expression
of zinc binding proteins during the acute phase response (APR) may play
an essential role in the conversion of the immune system from the adaptive
mode of reactivity to the boosting of natural immune host defense [16,17]
Because there is a drift during aging from prevalent adaptive immune reactions
towards natural immune mechanisms and to frequent APRs, it comes natural
that zinc-binding proteins show elevations with aging [15] However, memory
T cells are all right in old age, in spite of Zn deficiency. Moreover,
these changes are not inevitable as centenarians were found to have normal
Zn and binding protein values [18] It is also noteworthy that liver regeneration
was not affected in old mice with high MT and Zn levels in this organ[19].
This observation indicates that cell proliferation per se may not
be deleteriously affected by the zinc homeostatic regulatory system.
2.3
Neutrophil ageing and immunosenescence
Neutrophil
numbers are not lowered with age [20] and there is normal neutophilia to
infectioin [21]. Adhesion molecules are normal or may even be increased
[22,23] and bactericid innate recognition is all right [24] Contradictory
observations were made for neutrophil extravasation, chemotaxis and superoxide
production. Neutrophil reaction was reduced to GCSF but not to GMCSF. Significant
reduction was found in phagocytosis and cytotoxicity was declined towards
bacteria and yeast [25] However, it is not clear, how much of this functional
impairment is due to the ageing of neutrophils and to what extent is it
the consequence of glucocorticoid excess, which is characteristic of ageing
animals and man [15,26,27]. Hypopituitary patients show excess mortality
due to respiratory disease [28] which gives further emphasis to the relevance
of age related neuroendocrine alterations to immune abnormlities.
2.4
Apoptosis and aging
Apoptotic
(APO) phenomena are increased in ageing [29]. Tumor necrosis factor (TNF)
is also increased, as well as tumor necrosis factor receptor-I (TNFR-I),
which mediates APO on various target cells. In contrast, TNFR-II, which
conveys other actions of TNF, is decreased [30,31,]. Effector memory
T cells (e.g. CD28+) are increased during ageing and these cells are susceptible
to apoptosis [32]. However some subsets of memory T cells may be APO resistant
[33]. Replicative senescence may block APO [34] Several functions of polymorfonuclear
cells (e.g. killing, free radicals, chemotaxis, O3, lytic enzymes) are
decreased with ageing [1,35]. Cholesterol, which is often elevated in the
elderly, is important for signal transduction by membrane bound receptors
[1].
It
is apparent from this chapter that APO occurs more frequently in the elderly.
However, it is also apparent that programmed cell death remains an important
physiological regulatory mechanism for memory T cells, which show an increase,
rather than a decline with ageing.
2.5
MHC-unrestricted cytotoxity in ageing
Monocyte
and macrophage numbers and cytokine production are increased in the elderly
[36], and dendritic cells are unimpaired as well [37]. This assures excellent
antigen presentation as well as phagocytic/cytotoxic activity by these
cells. TNF alpha was not changed, whereas IFN gamma was increased in centenarians
[38]. Mature NK (CD56+) cells were elevated in the elderly [39], and NK
functions were not diminished with aging [40]. High NK numbers were observed
in centenarians [41]. Gamma/delta T cell cytotoxicity was preserved in
centenarians [42] and higher gamma-delta-T activation was observed in old
individuals [43]. Bone and muscle remodeling by the immune system was maintained
in the elderly [44,45]
This
chapter testifies that innate cytotoxic mechanisms are actually superior
in elderly people when compared to young individuals. This is coupled with
excellent antigen presentation and immunological memory. Moreover, immune
capability of centenarians is truly remarkable. All these facts support
the idea, that during successful ageing an immune disaster is not inevitable,
on the contrary, it is possible to suggest that the immune system keeps
adapting to age related changes in order to optimally fulfill its normal
functions.
2.6
MHC Polymorphism and ageing
Caruso
and colleagues conclude that there is no statistically significant relationship
between MHC-polymorphism and successful ageing [46] [Candore et al. 2004].
However, one must not forget that MHC polymorphism and immunological diversity
play a major role in survival at the time of major epidemics.
3.
AGEING OF THE ENDOCRINE SYSTEM
3.1
Neuroplascticity in the Human Hypothalamus During Ageing
Hofman
and Swaab [47] provides an accout of hypothalamic changes during ageing.
They point out that each group of cells (e.g. nuclei) in the hypothalamus
has have their own sex-specific pattern of ageing. Some nuclei become less
active, others become more active with age. Steroid hormones play a key
role in neuroplasticity and ageing.
This
story is very similar to what was said about the ageing immune system.
Both positive and negative changes occur, which implies regulation rather
then simple deterioration during ageing. Current evidence indicates that
the hypothalamus is the ultimate immunoregulator [48] [Berczi and Szentivanyi
2003c] and it is fudamental for the regulation of all other organs and
tissues in higher organisms, as is obvious from this volume. On this basis
one may suggest that the process of ageing also is under hypothalamic control.
Clearly this part of the central nervous sytem is involved in setting of
biological rhythms and adaptive variations. The lifespan of the organism
may be suggested as the ultimate rhythm to regulate. Elderly animals and
humans are typically characterized by the loss of rhythmicity of physiological
parameters and by the inability to adapt to environmental challenges, as
repeatedly pointed out in this volume.
3.2
The role of growth hormone signaling in the control of ageing
Growth
hormone plasma levels gradually decline during adult life. It is apparent
from the relevant literature that role of GH changes in different stages
of life. Excess GH during adulthood in animals and man shortens their lifespan.
Tradeoffs must exist between growth, reproduction and longevity. Low GH
levels may have a role in protecting the organism from cancer and other
age-related diseases. Subnormal GH levels affect body composition, muscle
and brain function, and are suspected of contributing to the deterioration
of quality of life in the elderly. However, the risks and benefits of anti-ageing
therapy with GH are not well understood and the concept of GH replacement
during “somatopause” is controversial [49]
It
seems very intriguing that GH has an influence on lifespan. Being an anabolic
hormone, excess GH must promote metabolic processes that are deleterious
for longevity. Growth hormone is the member of the growth and lactogenic
hormone (GLH) family, which include multiple isoforms of GH, prolactin
(PRL) and placental lactogenic hormones (PL). These hormones have overlapping
functions and are of fundamental importance in governing the growth, development
and bodily functions of higher animals for their life-cycle. On the basis
of the immunological effects of GLH hormones it was postulated that they
function as competence hormones for the immune system, and likely for all
other tissues and organs in higher animals [50, 51] Because of overlapping
functions between GH and PRL, GH or PRL deficiency alone rarely causes
severe problems due to compensation by the other hormone, if it is present
at normal levels. However, joint and complete deficiency has not been adequately
demonstrated to date [52]. Our experiments in hypophysectomized rats indicated
that animals lacking both hormones die of bone marrow and immune failure
and of cachexia within 6 weeks [53]. These observations indicate that PRL
alone is capable of maintaining vital bodily functions in hypophysectomized
rats. Redundancy exists within the GLH family and these hormones are indispensable
for the growth, development and functional maintenance of the body throughout
the entire lifespan of higher animals [50-53]. Consequently, it is reasonable
to suggest that GLH, rather than GH alone, should be viewed as functional
unit, when it comes to the assessment of biological functions and of the
impact on health and longevity.
3.3
Ageing and the adrenal cortex
Ageing
in healthy people is associated with the gradual decrease of adrenal dehydroepiandrosterone
(DHEA) secretion. This leads to a relative glucocorticoid excess during
ageing. At present, there is no clear indication that DHEA therapy would
work in the elderly [54]
DHEA
functions as a steroid hormone precursor, and its decline leads to androgen
and estrogen deficiency, whereas glucocorticoid levels are not changed
or may even be elevated during ageing. Whether or not these changes represent
adaptation to the changing internal milieu characteristic of ageing,
or may function as an important link between immune-, endocrine- and neuronal-senescence,
remains to be determined. In woman a major trigger of changes in steroid
hormone secretion is menopause. It is abundantly clear that steroid
hormones are major regulators in the body that includes the immune system
and that altered levels do have far reaching consequences [3, 55]
3.4
Hormonal changes in ageing men
A number
of age-related changes in men can ultimately lead to androgen deficiency.
Some of the symptoms and disorders frequently seen in elderly men (e.g.
loss of body mass, sexual dysfunction, osteoporosis, depression) have been
linked to low androgen levels. Up to one third of men beyond the age of
60 have low serum testosterone levels. Androgen supplementation for these
men is controversial at this time [56].. Circadian changes of testosterone
are lost in man during ageing [57,58].
There
is little doubt that testosterone declines with age, even wen levels do
not get subnormal in elderly man. A more serious problem may be the loss
of the ability for adaptive changes. This is indicated by the loss of the
circadian rhythm. Testosterone declines during trauma and inflammatory
disease, and exerts a major effect on the immune system, which has a bearing
on mortality [3]. Therefore, this hormone has a much wider biological potential
than originally anticipated, and this should be taken into consideration
in future investigations.
3.5
Ageing of the neuroendocrine circadian system
Changes
do occur in the neuroendocrine circadian system. The most frequent observation
is the reduction of circadian amplitude during ageing. With the reduction
of melatonin the information on time and seasons is decreased. This leads
to reduced adaptability, the loss of seasonal adjustments and more susceptibility
to climatic change and in general to stress [59]
Adrenal
cortisol is maintained, whereas DHEA abruptly declines during ageing. The
circadian rhythm of ACTH decreases or is abolished in aged rats. In man
melatonin decreases during the sixties and seventies, but later it levels
off. Many factors influence the hypothalamus-pituitary-thyroid axis. It
is inhibited by sleep deprivation, iodine deficiency. Fasting suppresses
TSH levels, which may be restored by leptin. Geographical changes
and climatic changes, such as cold increase T4 levels, but not in the elderly
[59].
The
circadian rhythm of prolactin continues in the elderly. High levels are
secreted during REM sleep. Nursing over-rules this regulation. Numerous
medications stimulate PRL secretion (e.g. psychoactive drugs). In sexually
mature woman, cycling PRL is increased. Stress also increases PRL
serum levels [59].
Catecholamines
drop with age and beta-adrenergic receptors are impaired. However dopamine
(DOP) cells increase in the substancia nigra up to age 60. Sympathetic
nervous responses to stress increase with age. Norepinephrine production
and release is up and blood pressure is elevated, which may be decreased
by bromocriptine. Urinary catecholamine levels are higher in hypertension.
Melatonin antagonizes these changes [59].
There
is no doubt that the neuroendocrine system plays a major role in adaptation
to environmental factors and to stressors. The diurnal rhythm of hormones
is related to the rhythm of daytime activity, energy spending and catabolism
and night-time regeneration and anabolism. The loss of circadian rhythm
of various hormones impairs adaptability as well as proper regeneration
and maintenance of good health.
It
is remarkable that PRL levels and rhythms are maintained in the elderly.
Indeed, PRL is required to maintain vital bodily functions. Animal experiments
showed, that if this hormone is lost, it has fatal consequences [53]. Therefore,
GH may decline with age because PRL is able to maintain all the vital functions
GH would do, without the deleterious effects that elevated GH levels may
produce [49].
3.6
Melatonin rhythms, melatonin supplementation and sleep in old age
After
80 years of age, there are no rhythms of melatonin secretion and there
is no diurnal periodicity. Rhythms are regulated by noradrenaline,
which is increased. However, melatonin did not decline in extremely healthy
people. At present there is no clear evidence for the benefit of melatonin
treatment [60,61].
As
already pointed out, the lack of biological rhythms leads to the loss of
adaptation and impair the daily regeneration of the body. These are very
significant problems of most elderly people.
4.
AGEING OF THE NERVOUS SYTEM
4.1
Age-related changes of the human autonomic nervous system
Ageing
is accompanied by significant structural and functional modifications of
the cardiovascular system. Cardiovagal modulation is decreased with increasing
age indicated by a decrease of cardiovagally mediated indices of heart
rate variability. Sympathetic outflow to the heart is elevated, however,
it is not well transformed into an enhanced end-organ response because
of a decrease of alpha - and beta -adrenergic receptor potency. Orthostatic
dysregulation is common in the elderly for several reasons; one major point
is that the baroreflexes are impaired with increasing age [62].
4.2
Age-related alterations in autonomic nervous innervation
The
thymus is innervated, alpha - and beta adrenergic receptors are present
and there is evidence for the neural regulation of T cell subsets. Of the
neuropeptides substance P, calcitonin gene related peptide, meth-enkephalin,
vasoactive intestinal peptide, cholecystokinin, neurotensin, intreleukin-1,
C-reactive protein and arginine vasopressin are present in thymic nerves.
Noradrenalin (NE) is diminished in spleen of old rats in all compartments.
There is peripheral neuropathy suggesting metabolic insults. Heightened
sympathetic activity is present in the remaining nerves. NE treatment depletes
NE nerves in the rat. Bacterial lipopolysaccharide (LPS) has no effect,
but IL-2 releases NE. L-deprenyl, a monoamine oxidase-B (MAO-B) inhibitor,
partially restores NA in 21 month-old rats. Natural killer cell activity,
Concanavalin-A and IL-2 responses are increased by such treatment.
Immune
changes in aged humans and animals are variable. Sympathetic nerves may
stimulate immunity and inhibit B cells and the TH1 response. The effect
is variable, depending on the circumstances. Compensatory mechanisms operate
in order to achieve “fine tuning” of the immune system. T cell memory is
increased with ageing and this requires adjustments [63-71].
This
chapter sums up very well the facts and dilemmas of ageing and neural regulation
of the immune system. Yes, there are definite signs of deterioration and
malfunction, but neither the regulatory influence of sympathetic nerves,
nor the age related deterioration of immune function is etched in stone.
One reason for this must be that no differentiation is made between ageing
with disease and healthy ageing. As for the fine-tuning of the immune system
by the autonomic nerves system, this must be viewed as an important mechanism
for the adaptive modulation of immune function. However, it seems certain
that T cell memory is maintained, no matter what age-related changes are
present.
4.3
Ageing and the neuroendocrine system of the gut
Everything
declines in the gut with ageing, somatostatin is decreased and so is gastrin,
more so in males than in females. Endocrine cells are all right in the
large intestine. Serotonin is increased in the small intestine, so are
peptide YY and enteroglucagon . In BALB/c/nunu mice, which do not have
thymuses, endocrine cells are increased in the gastrointestinal tract with
age. In general gastrointestinal nerve cells decrease in man and in the
guinea pig with ageing, but not in the mouse [72-74].
Here
again the general rule is decline, but the mouse is exception and in thymus-less
nude mice actually there is an increase of gastrointestinal nerve cells
with age. Does this signify the existence of as yet unsuspected influence
of the thymus or of T cells on gastrointestinal innervation? Future studies
are to decide this question.
4.4
Nutrition and brain ageing
Ageing
is characterized by the loss of capacity to maintain homeostasis. During
dietary caloric restriction more synapses are present in the brain with
larger transmission area. Vitamin E deficiency leads to less and larger
synapses. Synapses enlarge in order to compensate for the decreased numbers.
Ageing is accelerated under these conditions. Alcohol impairs synaptic
potential by disturbing lipid metabolism [75,76]
Brain
ageing may be thought of as a particular condition in which specific pathological
changes are found without clinically evident manifestations, because nerve
cell alterations are continuously counteracted by compensating reactions.
As a consequence, deterioration of function occurs when the number of neurons
and of their connections decrease below a critical reserve level and coping
with environmental stimulations becomes difficult [77,78].
There
is no doubt that optimal nutrition is fundamental to good health. Over-nutrition
is just as damaging as is under-nutrition. Food does not only pose “oxidative
damage”, but always contain multiple carcinogenic and other harmful substances.
Toxic substances are also produced during the process of digestion. These
insults must be adequately handled by the defence systems of the body in
order to survive and to maintain good health. Clearly, understanding and
practising proper nutrition is one of the key concerns of ageing and of
public health today.
4.5
Ageing-related role of nitric oxide in the brain
This
review points out the possible functional link between age-dependent decrease
in neural nitric oxide synthase (nNOS) activity and increase in inducible
NOS (iNOS) expression in the brain. Evidence is presented for the existence
of infections in the brain, which is one of the hallmarks of ageing, and
apparently trigger “spontaneous” iNOS expression. The future treatment
of aged people is also described, which takes into consideration these
facts [79]..
The
problem of persistent infections is not resolved at the present time. Most
scientists tend to regard them as harmful, yet they were observed to afford
protection to the host on repeated occasions. For instance it is
well known about the herpes simplex virus persists within the CNS
in most people and that it becomes readily activated in certain individuals
in response to various stressors [80]. In the overwhelming majority of
the cases there is a harmless self-resolving infectious lesion, which heals
spontaneously, and hardly can be classified as dangerous. Actually there
is a real possibility that the cytokines generated during this benevolent
immune activation are quite beneficial to the individual. Recent observations
revealed, that inflammation itself has protective value for the nerves
system, possibly via T cell derived nerve growth factor [81]. Moreover,
the lipopolysaccharide endotoxin of intestinal gram negative bacteria,
which are absorbed from the gut during trauma and shock, functions as a
powerful immune activator. Clearly, LPS functions to activate the innate
immune system in stressful conditions, and therefore, it may be considered
as one of the remedies for self-medication in emergency situations [82].
Persistent neurotrop viruses may in fact fulfill a similar mission. It
is very well established that iNOS is an important weapon against infectious
agents, and may be used as such in the ageing brain. It is also clear that
LPS, iNOS and excessive activation of persistent viruses may have harmful
effects. These questions await further clarification.
5.
LINKS BETWEEN ONE GLOBAL SYSTEM AND ANOTHER GLOBAL SYSTEM DURING THE AGEING
PROCESS
5.1
Plasticity of neuro-endocrine-thymus interactions during the ontogeny of
aging: the role of zinc
Current
evidence strongly suggests that thymic involution is a phenomenon secondary
to age-related alterations in neuroendocrine-thymus interactions.
The disruption of these interactions in old age is responsible for age-associated
immune-neuroendocrine dysfunctions. Thymic reconstitution may be achieved
by GH, thyroid hormones, and LHRH, which act on specific hormone receptors
on thymocytes and on thymic epithelial cells. Melatonin may also act through
specific receptors on T-cells. Zinc finger proteins are important because
they regulate gene expression for hormone receptors. However, the effect
of zinc is multifaceted. Zinc-dependent thymic hormone is required for
intrathymic T-cell differentiation and maturation as well as for the homing
of stem cells into the thymus. Therefore, the role of zinc is crucial in
neuroendocrine-thymus interactions and for the maintenance of thymus function
(e.g. by GH, thyroid hormones or melatonin) and for improving adaptive
immunocompetence during ageing [83]
The
traditional view that thymic involution is responsible for immune deterioration
during agEing may now be challenged. As is obvious from this volume, memory
T lymphocytes increase with age. This means that memory cells are being
accumulated gradually towards most, if not all, of the environmental pathogens.
Therefore, there is little if any need for naïve T cells freshly released
by the thymus. However, the thymus can be re-activated again, even at advanced
age [84,85]. This suggests, that thymic involution may be a physiological
phenomenon, at least in part, during successful agEing. Thymic involution
may also occur under pathophysiological conditions, during the acute phase
response (APR), or febrile illness, which is initiated by the immune system
in response to infection or to other forms of traumatic injury. Cells of
the monocyte/macrophage lineage release massive amounts of IL-1, IL-6 and
TNF-alpha into the circulation, which in turn trigger profound neuroendocrine
and metabolic changes. The hypothalamus-pituitary-adrenal axis is activated,
the thymus undergoes a profound involution, due to the apoptotic effect
of glucocorticoids and of TNF, and to the relative deficiency of growth
and lactogenic hormones, which is coupled with zinc deficiency. The biological
significance of APR is that it is capable of switching over the immune
system from the adaptive mode of reactivity to the amplification of natural
immune mechanisms. APR is a highly coordinated emergency defense reaction,
which mobilizes all the resources of the body in the interest of survival.
Many individuals exhibit signs of low-grade APR during ageing [15,17].
Therefore, thymic involution may not be the primary cause for immunodeficiency
in the aged, but age-related diseases, which may be the consequence of
immunodeficiency, would accelerate thymic involution. Hence, thymic involution
is also associated with pathological conditions. Would the improvement
of thymic function lead to health benefit in the elderly? Current indications
are that it would indeed do so.
5.2
Adverse glucocorticoid actions and their relevance to brain ageing
This
chapter discusses the concepts of stress and of homeostasis. It is presented
that the HPA axis becomes gradually more active with aging. Glucocorticoids
affect the CNS, immunocompetence, and inflammation. Although a fair amount
of information is available, the biological significance of the observations
is not always clear [86,87].
5.3
Neuroendocrine immune aspects of osteoporosis during the ageing process
Age
related alterations of gonadal and thyroid hormones and of vitamin D leads
to loss of bone mass. Alpha melanocyte stimulating hormone is a novel bone
regulator as is leptin. Serum osteoprotegrin is increased with age [88-91].
One
may remark here that osteoclasts belong to the monocyte/macrophage family
of myeloid cells and they respond to immune-derived cytokines, especially
to IL-6. IL-6 has a stimulatory effect on osteoclasts, which leads to accelerated
bone resorption. Estrogens suppress IL-6 production. Estrogen deficiency
develops abruptly in females after the menopause and to a lesser extent
also in males, due to androgen deficiency. This will lead to increased
secretion of IL-6 and consequently to accelerated bone loss [55].
6.
THE AGEING PROCESS AND CHRONIC INFLAMMATORY DISEASE
6.1.
Neuroendocrine immune mechanisms of accelerated ageing in patients with
chronic inflammatory diseases
Straub
and colleagues consider the deleterious effects of chronic inflammatory
disease, which accelerates ageing. Indeed inflammatory disease is characterized
by immune activation and cytokine release, which invariably elicit neuroendocrine
and metabolic alterations as correctly pointed out by the authors. Changes
in glucocorticoids, androgens, estrogens and vitamin D and the altered
metabolism affect immune function, the nervous system and bone metabolism.
It is concluded that more information is required before a rational approach
may be adapted for therapy [92]
Although
there is little doubt that chronic inflammation has an enormous thaw on
the patient, one should keep in mind that inflammation is a defense reaction,
which should protect the host. Is this possible in chronic inflammation?
Recent observations in experimental autoimmune encephalitis of rats, a
chronic inflammatory disease with relapses, demonstrated that indeed, inflammation
has protective value [81].
6.2
Thyroid autoimmunity and ageing
Thyroid
autoantibodies and subclinical hypothyroidism increase with ageing. However,
thyroid autoantibodies are rare in centenarians and in other highly selected
aged populations. This suggests that thyroid autoimmunity is not the consequence
of the ageing process itself, but rather, an expression of age-associated
disease. Thyroid autoimmunity and/or thyroid dysfunction may have an etiological
role in several age-associated diseases, although the precise mechanisms
involved remain to be elucidated [93].
This
chapter clearly demonstrates that successful ageing is not characterized
by autoimmune reactions, whereas autoimmunity itself may be the cause of
age-associated diseases. Indeed, it is highly desirable to keep these findings
in mind when trying to investigate the problem of ageing. Even if most
people age with disease, the goal should be to achieve successful, healthy
ageing, whenever possible.
6.3
The clinical importance of proinflammatory cytokines in elderly populations
Low-grade
increases in plasma level of inflammatory mediators are characteristic
of age-associated pathology, including cardiovascular diseases, dementia
and sarcopenia. Inflammatory cytokines, such as TNF and IL-6, act as independent
predictors of high mortality risk. It is suggested that systemic low-grade
inflammation provide a common link between ageing, body composition, and
life style factors on one hand and age-related diseases and mortality on
the other [94].
The
senile immune system is clinically relevant. It is likely that TNF and
IL-6 trigger age associated pathology. Cardiovascular disease and dementia
are prevalent in the elderly. TNF is associated with dementia in the very
old (>80 years of age) and IL-6 may play a role in thromboembolic complications
and cardiovascular disease in middle-aged people. Monocytes are in a pre-activated
state in the elderly. Some of the possible reasons for the development
of disease are: continuous antigenic load, stressors, “inflam-ageing” and
dys-regulated acute phase response [94,95].
TNF
and IL-6 promoter polymorphism may play an important role in disease development
[96,97]. Body fat directly correlates with TNF [98] and with leptin [99]
Endocrinosenescence contributes to immunosenescence. The loss of sex hormones
leads to immunosuppression and to a low grade inflammatory milieu in the
elderly [100]
The
results presented in Figure 4 of this chapter support the idea of a proinflammatory
milieu in the elderly. Peripheral blood cells from young individuals produced
more TNF after in vitro stimulation by LPS than did cells from old people,
yet the blood level of TNF in the elderly was significantly higher after
LPS treatment. Infections, especially Chlamydia and bacteriuria are frequent
in the elderly [101,102].
This
chapter is an excellent demonstration of the relevance of Neuroimmune Biology
to Clinical Practice. Physicians have always been concerned with the patient’s
well being, and for that they had to understand how the body works. This
chapter presents information from the area of Molecular Biology, Immunology,
Microbiology, Endocrinology, Neurology, Food Science, Pathology, Gerontology,
all of which are integrated into a modern version of Clinical Medicine.
The pathophysiological mechanisms that are discussed in the context of
age-related diseases are compelling and are testable for further confirmation.
Indeed, this is what should be the ultimate mission of Neuroimmune Biology,
to understand the biology of man and of higher animals in their entire
complexity, and to apply the newly found knowledge to the benefit of all.
7.
CONCLUSIONS
7.1
New anti ageing strategies related to neuroendocrine immune interactions
This
chapter demonstrates that the agents/methods used for the prolongation
of life span influence growth hormone, prolactin, zinc or apoptosis. The
new agents act on one of these basic factors in aging [103]
This
chapter illustrates very well again the relevance of Neuroimmune Biology
to practical Medicine. It was postulated a decade ago that members of the
growth and lactogenic hormone family function as competence hormones
that regulate growth and all functions in higher animals [50]. It has also
been established that hypohysectomized rats rely on residual PRL for survival.
If this PRL is neutralized by antibodies, they will die within 6 weeks
[53]. Now several chapters, including this one, lends further support to
the hypothesis that GLH maintain vital bodily functions and are essential
for survival and for longevity.
7.2
The future
Much
of the global problems of our times come from the fact that man aspires
to bypass and overrule the laws of Mother Nature. Ageing is no exception,
the quest is on for longer and healthier life, and in actual fact significant
increases are seen in the mean life-span globally, with the Western world
in the lead. Some countries are much overpopulated, and in others the percentage
of elderly people is steadily increasing. This poses ever-increasing problems
on Society and on future generations. Global overpopulation is already
threatening us with catastrophe, so why push our luck any further? Why
study ageing at all?
Well,
for most people ageing means diseases, often suffering from lengthy and
debilitating conditions. Nobody will argue against studying and preventing
age related diseases. Better health and better quality of life for all
people are noble causes and is highly desirable to pursue. One may
also argue that healthy people would be productive longer, so the burden
posed on Society would decrease. The scientific value of understanding
the ageing process is immense from the point of view of understanding our
biology, but also for gaining better insights to the pathobiology of diseases.
This
volume sheds light on many aspect of the problem of ageing. The most important
message is that the Neuroimmune Regulatory Network plays a fundamental
role in the ageing process. Indeed, this book is living testimony for
the validity and significance of Neuroimmune Biology to aging. NIB provides
for a comprehensive way of viewing and investigating biological problems,
such as ageing. For the first time ageing is looked upon from the special
perspectives of NIB, the science of systemic regulation of higher organisms.
Already there is compelling evidence that this science is highly relevant
to Clinical Medicine.
Is
it possible to achieve immortality? It is now clear that most if not all
of the biological processes, which decline during ageing, are reversible.
This would suggest that it would be feasible to achieve immortality in
macro-organisms. Ageing seems to be genetically programmed. However some
aspects of ageing may be related to the very fundamental properties of
matter and energy that dominate our world. So far we have not achieved
a clear understanding of the rules governing the fundamental forces of
our universe.
Larbi
A, Fülöp T Apoptosis and Aging. In “The Neuroendocrine Immune
Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds. Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
2
Nagy
E, Berczi I, Baral E. Combination immunotherapy of cancer. In “Neuroimmune
Biology Volume 1: New foundation of Biology” Berczi I, Gorczynski R, Editors,
Elsevier, 2001;pp.417-432. S.C.
3
Berczi
I, Nagy E, Baral E, Szentivanyi, A. Sterid Hormones. In “Neuroimmmune Biology,
Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress”. Berczi
I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 221-270.
4
Solana
R, Pawelec G. Immunosenescence. . In “The Neuroendocrine Immune Network
in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani E. Eds.,
Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in
this volume)
5
Castle,
K. Uyemura, W. Crawford, W. Wong and T. Makinodan, Antigen presenting cell
function is enhanced in healthy elderly. Mech.Ageing Dev., 107 (1999)
137-145.
6
Chamberlain
WD, Falta MT,. Kotzin BL. Functional subsets within clonally expanded CD8(+)
memory T cells in elderly humans. Clin Immunol 2000;94:160-172.
7
Wikby
A Johansson B, Ferguson F, Olsson J. Age-related changes in immune parameters
in a very old population of Swedish people: a longitudinal study.
Exp Gerontol 1994;29:531-541
8
Wikby
A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4
lymphocyte subsets, T cell proliferation responses and non-survival in
the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing
Dev1998;1002:187-198.
9
Pawelec
G, Ouyang Q, Colonna-Romano G, Candore G, Lio D, Caruso C. Is human immunosenescence
clinically relevant? Looking for 'immunological risk phenotypes'.
Trends Immunol 2002;23:330-332.
10
Khan
N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L,
Moss PA. Cytomegalovirus seropositivity drives the CD8 T cell repertoire
toward greater clonality in healthy elderly individuals. J Immunol
2002;169:1984-92
11
Ouyang
Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AL, Travers P, Pawelec
G. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors
for a single dominant CMV epitope in the very old. J Clin Immunol
2003;23:247-257
12
Ouyang
Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic
S, Dodi T, Pawelec G. An age-related increase in the number of CD8(+) T
cells carrying receptors for an immunodominant Epstein-Barr virus (EBV)
epitope is counteracted by a decreased frequency of their antigen-specific
responsiveness. Mech Ageing Dev 2003;124:477-485.
13
Ouyang
Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher
H, Pawelec G. Age-associated accumulation of CMV-specific CD8(+) T cells
expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1).
Exp Gerontol 2003;38:911-920.
14
Berczi
I. Neuroendocrine defence in endotoxin shock. A review. Acta Microbiol
Hung 1993:40:265-302
15
Berczi
I, Szentivanyi A. The acute phase response. In Neuroimmmune Biology, Volume
3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I,
Szentivanyi A, Editors, Elsevier, Amsterdam, 2003a; pp. 463-494
16
Mocchegiani
E, Giacconi R, Muti E, Muzzioli M, Cipriano C. Zinc-binding proteins (metallothionein
and a-2 macroglobulin) as potential biological markers of immunosenescence.
In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology Volume
4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series Eds.
Elsevier, Amsterdam, 2004 pp. (in this volume)
17
Haeryfar
SMM, Berczi I. The thymus and the acute phase response. Cell Mol Biol 47:145-156,2001
18
Mocchegiani
E, Giacconi R, Cipriano C, Muzzioli M, Gasparini N, Moresi R, Stecconi
R, Suzuki H, Cavalieri E, Mariani E. MtmRNA gene expression, via IL-6 and
glucocorticoids, as potential genetic marker of immunosenescence: lessons
from very old mice and humans. Exp Gerontol 2002;37:349-357.
19
Mocchegiani
E, Verbanac D, Santarelli L, Tibaldi A, Muzzioli M, Radosevic-Stasic B,
Milin C. Zinc and metallothioneins on cellular immune effectiveness during
liver regeneration in young and old mice. Life Sci 1997;61:1125-1145
20
Chatta
GS, Andrews RG, Rodger E, Schrag M, Hammond WP, Dale DC. Hematopoietic
progenitors and aging: alterations in granulocytic precursors and responsiveness
to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 1993;M207-M212.
21
Butcher
S, Chahal H, Lord JM. The effect of age on neutrophil function: loss of
CD16 associated with reduced phagocytic capacity. Mech Ageing Dev 2001;122:20.
22
Esparza
B, Sanchez H, Ruiz M, Barranquero M, Sabino E, Merino F. Neutrophil function
in elderly persons assessed by flow cytometry. Immunol Invest 1996; 25:185-90.
23
Rao
KMK. Age-related decline in ligand-induced actin polymerisation in human
leukocytes and platelets. J Gerontol 1986;41: 561-566.
24
Emanuelli
G, Lanzio M, Anfossi T, Romano S, Anfossi G, Calcamuggi G. Influence of
age on polymorphonuclear leukocytes in vitro: phagocytic activity in healthy
human subjects. Gerontology 1986; 32:308-16.
25
Butcher
SK, Wang Q, Lascelles D, Lord JM. Neutrophil ageing and immunosenescence.
In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology Volume
4. Straub RH, Mocchegiani E. Eds. Berczi I, Szentivasnyi A. Series Eds.
Elsevier, Amsterdam, 2004 pp. (in this volume)
26
Ferrari
E, Casarotti D, Muzzoni B et al. Age-related changes of the adrenal secretory
pattern: possible role in pathological brain aging. Brain Res Brain Res
Rev 2001; 37:294-300.
27
Berczi
I, Szentivanyi A. Immunodeficiency. In Neuroimmmune Biology, Volume 3:
The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi
A, Editors, Elsevier, Amsterdam, 2003b; pp.537-558.
28
Tomlinson
JW, Holden N, Hills RK et al. Association between premature mortality and
hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet
2001; 357:425-31.
29
Krammer
PH. CD95’s deadly mission in the immune system. Nature 2000;407 :789-795
30
Stosic-Grujicic
SS, Lukic ML. The production of TNF, IL-1 and IL-6 in cutaneous tissues
during maturation and aging. Adv Exp Med Biol 1995;371:411-414
31
Screaton
G, Xu X.-N. T cell life and death signaling via TNF-receptor family members.
Cur. Opin Immunol 2000;12:316-3222
32
McLeod
JD, Walker LSK, Patel YI., Boulougouris G, Sansom DM. Activation of human
T cells with superantigen (SEB) and CD28 confers resistance to apoptosis
via CD95. J Immunol 1998;160 :2072-2079.
33
McLeod
JD Apoptotic capability in ageing T cells.Mech Age Dev 2000; 121:151-159
34
Spaulding
C, Guo W, Effros RB. Resistance to apoptosis in human CD8+ T cells that
reach replicative senescence after multiple rounds of antigen-specific
proliferation. Exp Gerontol 1999; 34:633-644
35
Fulop
TJr, Foris G, Worum I., Leovey A.. Age-dependent alterations of Fc receptor
mediated effector functions of human polymorphonuclear leukocytes. Clin.
Exp. Immunol. 1985;61: 425-432
36
Gardner
ID, Lim ST, Lawton JWM. Monocyte function in ageing humans. Mech Ageing
Dev 1981;16:233-239
37
Saurwein-Teissl
M, Schonitzer D, Grubeck-Loebenstein B. Dendritic cell responsiveness to
stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol
1998;33:625-631
38
Miyaji
C, Watanabe H, Toma H, Akisaka M, Tomiyama K, Sato Y, Abo T. Functional
alteration of granulocytes, NK cells, and natural killer T cells in centenarians.
Hum Immunol 2000;61:908-916
39
Borrego
F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, Pena J, Solana
R. NK phenotypic markers and IL2 response in NK cells from elderly people.
Exp Gerontol 1999;34:253-265
40
Facchini
A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA. Increased number
of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased
NK activity during human ageing. Clin Exp Immunol 1987;68:340-347
41
Sansoni
P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri
G, Ortolani C, Forti E, et al. Lymphocyte subsets and natural killer cell
activity in healthy old people and centenarians. Blood 1993;82:2767-2773
42
Fagnoni
FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, Franceschi
C, Passeri M, Sansoni P. Expansion of cytotoxic CD8+ CD28- T cells in healthy
ageing people, including centenarians. Immunology 1996;88:501-507
43
Colonna-Romano
G, Potestio M, Aquino A, Candore G, Lio D, Caruso C. Gamma/delta T lymphocytes
are affected in the elderly. Exp Gerontol 2002;37:205-211
44
Mariani
E, Ravaglia G, Meneghetti A, Tarozzi A, Forti P, Maioli F, Boschi F, Facchini
A. Natural immunity and bone and muscle remodelling hormones in the elderly.
Mech Ageing Dev 1998;102:279-292
45
Provinciali
M, Donnini, A, Re F. MHC-unrestricted cytotoxicity in ageing In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds. Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
46
Candore
G, Caruso C, Romano GC, Lio D, Major histocompatibility complex polymorphisms
and ageing. In “The neuroendocrine Immune Network in Ageing”, Neuroimmune
Biology Volume 4. Straub RH, Mocchegiani E. Eds. Berczi I, Szentivasnyi
A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in this volume)
47
Hofman
MA, Swaab DF. Neuroplascticity in the Human Hypothalamus During Aging.
In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology Volume
4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series Eds.
Elsevier, Amsterdam, 2004 pp. (in this volume)
48
Berczi
I, Szentivanyi A. The immune-neuroendocrine circuitry. In Neuroimmmune
Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress.
Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003c; pp. 561-592.
49
Bartke
A, Heiman M, Turyn D, Dominici F. Kopchick JJ. The role of growth hormone
signaling in the control of aging. In “The neuroendocrine Immune
Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
50
Berczi
I. The role of the growth and lactogenic hormone family in immune function.
Neuroimmunomodulation 1994;1:201-216
51
Berczi
I, Szentivanyi A. Immunocompetence. In Neuroimmmune Biology, Volume 3:
The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi
A, Editors, Elsevier, Amsterdam, 2003e; pp. 281-299.
52
Berczi
I. Foreword: The Neuroimmune Biology of Growth and Lactogenic Hormones.
In “Neuroimmune Biology Volume 2: Growth and Lactogenic Hormones”. Matera
L, Rapaport R, Editors, Elsevier, Amsterdam, 2002;pp. v-xiv
53
Nagy
E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival.
Endocrinology 1991;128:2776-2784
54
Lamounier-Zepter
V, Bornstein SR. Aging and the adrenal cortex. In “The neuroendocrine Immune
Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
55
Nagy
E, Baral E, Berczi I. Immune System.: In "Handbook of Experimental Pharmacology",
Estrogens and anti-estrogens. Section IV. Physiology and Pathophysiology
of Estrogens. M. Oettel, ed. in chief, Springer-Verlag 1999, 135/I:343-351
(A).
56
Plas
E, Madersbacher S, Berger P. Hormonal changes in aging men. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
57
Bremner
WJ, Vitiello V, Prinz PN Loss of circadian rhythmicity in blood testosterone
levels with ageing in normal men. J Clin Endocrinol Metab 1983;56:1278-1281.
58
Bremner
WJ, Vitiello V, Prinz PN Loss of circadian rhythmicity in blood testosterone
levels with ageing in normal men. J Clin Endocrinol Metab 1983;56:1278-1281.
59
Touitou
Y, Haus E.: Aging and the endocrine circadian system. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
60
Riemersma
RF Mattheij CAM, Swaab DF, Van Someren EJW. Melatonin rhythms, melatonin
supplementation and sleep in old age. In “The neuroendocrine Immune Network
in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani E. Eds.,
Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in
this volume)
61
Zeitzer
JM, et al., Do plasma melatonin concentrations decline with age? Am J Med,
1999;107:432-6.
62
Agelink
MW, Sanner D, Ziegler D. Age-related changes of the human autonomic nervous
system. In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology
Volume 4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series
Eds. Elsevier, Amsterdam, 2004 pp. (in this volume)
63
Bellinger
DL, Madden KS, Lorton D. Age-Related Alterations in Autonomic Nervous Innervation.
In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology Volume
4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series Eds.
Elsevier, Amsterdam, 2004 pp. (in this volume)
ThyagaRajan
S, Felten SY, Felten DL. Restoration of sympathetic noradrenergic
nerve fibers in the spleen by low doses of L-deprenyl treatment in young
sympathectomized and old Fischer 344 rats. J Neuroimmunol 1998;81:144-157.
66
Caruso
C, Candore G, Cigna D, DiLorenzo G, Sireci G, Dieli F, Salerno A.
Cytokine production pathway in the elderly. Immunol Res 1996; 15:84-90.
67
Rink
L, Cakman I, Kirchner H. Altered cytokine production in the elderly.
Mech Ageing Dev 1998;15:199-209.
68
Hobbs
MV, Weigle WO, Noonan DJ, Torbett BE, McEvilly RJ, Koch RJ, Cardenas GJ,
Ernst DN. Patterns of cytokine gene expression by CD4+ T cells from
young and old mice. J Immunol 1993;150:3602-3614.
69
Hobbs
MV, Weigle WO, Ernst DN. Interleukin-10 production by splenic CD4+
cells and cell subsets from young and old mice. Cell Immunol 1994;154:264-272.
70
Utsuyama
M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K, Hashimoto
W, Sato K. Differential age-change in the numbers of CD4+CD45RA+
and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing
Dev 1992;63:57-68.
71
Jackola
DR., Ruger JK, Miller RA. Age-associated changes in human T cell
phenotype and function. Aging 1994;6:25-34.
72
El-Salhy
M. Aging and the neuroendocrine system of the gut. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
73
Kvetnoy
I, Popuichiev V, Mikhina L, Anisimov V, Yuzhakov V, Konovalov S, Pogudina
N, Franceschi C, Piantanelli L, Rossolini G, Zaia A, Kventania T, Hernandez-Yago
J, Blesa JR. Gut neuroenocrine cells: relation to the proliferative activity
and apoptosis of mucous epitheliocytes in aging. Neuroendocrinol Lett 2001;22:337-341.
74
El-Salhy
M, Sandström O, Holmlund F. Age-induced changes in the enteric nervous
system in mouse. Mech Ageing Dev 1999;107:93-103.
75
Bertoni-Freddari
C, Meier-Ruge W, Ulrich J. Age-dependent effect of ethanol on the intranuclear
ionic content in hippocampal CA1 pyramidal cells. Adv. Biosci. 71, 263-267,
1988.
76
Bertoni-Freddari
C, Fattoretti P, Casoli, T, Di Stefano G, Solazzi M, Giorgetti B, Balietti
M. Modulating effects of nutrition on brain aging. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
77
Meier-Ruge.
Senile dementia - a disease of exhaustion of functional brain reserve capacity.
Excer. Med. Curr. Clin. Pract. Ser. 59, 371-375, 1990.
78
Meier-Ruge
W, Iwangoff P, Bertoni-Freddari C. What is primary and what secondary for
amyloid deposition in Alzheimer’s disease. Ann. N.Y. Acad.
Sci. 719, 230-237, 1994.
79
Mariotto
S, Miscusi M, Persichini T, Colasanti M, Suzuki H. Ageing-related role
of nitric oxide in the brain. In “The neuroendocrine Immune Network in
Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani E. Eds.,
Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in
this volume).
80
Berczi
I, Baragar FD, Chalmers IM, Keystone EC, Nagy E, Warrington RJ. Hormones
in self tolerance and autoimmunity: a role in the pathogenesis of rheumatoid
arthritis? Autoimmunity 1993;16:45-56
81
Berczi
I, Szentivanyi A. Nerve growth factror, leptin and neuropeptides. In “Neuroimmmune
Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress.
Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003f; pp. 181-189.
82
Berczi,
I. Neurohormonal host defence in endotoxin shock. Ann. N.Y. Acad. Sci.
840: 787-802,1998.
83
Mocchegiani
E, Giacconi R, Muti E, Muzzioli M, Cipriano C. Pasticity of neuroendocrine-thymus
interactions during ontogeny and aging: Role of Zinc. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
84
Shiraishi
J, Utsuyama M, Seki S, Akamatsu H, Sunamori M, Kasai M, Hirokawa K.Essential
microenvironment for thymopoiesis is preserved in human adult and aged
thymus. Clin Dev Immunol. 2003;10:53-9.
85
Berzins
SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL.
Thymic regeneration: teaching an old immune system new tricks. Trends Mol
Med. 2002;8:469-76.
86
Dinkel
K, Sapolsky RM. Adverse glucocorticoid actions and their relevance to brain
ageing. In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology
Volume 4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series
Eds. Elsevier, Amsterdam, 2004 pp. (in this volume)
87
Gardner
EM, Murasko DM. Age-related changes in Type 1 and Type 2 cytokine production
in humans. Biogerontology 2002;3(5):271-90.
88
Peterlik
M. Neuroendocrine immune aspects of osteoporosis during the ageing process.
In “The neuroendocrine Immune Network in Ageing”, Neuroimmune Biology Volume
4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi A. Series Eds.
Elsevier, Amsterdam, 2004 pp. (in this volume)
89
Cornish
J, Callon KE, Mountjoy KG, Bava U, Lin JM, Myers DE, Naot D, Reid IR. {alpha}-Melanocyte
stimulating hormone ({alpha}-MSH) is a novel regulator of bone. Am J Physiol
Endocrinol Metab 2003;4:4.
90
Li
H, Matheny M, Nicolson M, Tumer N, Scarpace PJ. Leptin gene expression
increases with age independent of increasing adiposity in rats. Diabetes
1997;46:2035-2039.
91
Kudlacek
S, Schneider B, Woloszczuk W., Pietschmann P, Willvonseder, R. Serum levels
of osteoprotegerin increase with age in a healthy adult population. Bone
2003.
92
Straub
RH, Schölmerich J, Cutolo M. Neuroendocrine immune mechanisms of accelerated
aging in patients with chronic inflammatory diseases. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
93
Mariotti
S, Pinna G, Pinchera A. Thyroid autoimmunity and ageing. In “The neuroendocrine
Immune Network in Ageing”, Neuroimmune Biology Volume 4. Straub RH, Mocchegiani
E. Eds., Berczi I, Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004
pp. (in this volume)
94
Bruunsgaard
H, Krabbe K. The clinical importance of proinflammatory cytokines in elderly
populations. In “The neuroendocrine Immune Network in Ageing”, Neuroimmune
Biology Volume 4. Straub RH, Mocchegiani E. Eds., Berczi I, Szentivasnyi
A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in this volume)
95
Krabbe
K, Bruunsgaard H, Hansen CM, Møller K, Fonsmark L, Quist J et al.
Aging is associated with a prolonged fever response in human endotoxemia.
Clin Diagn Lab Immunol 2001; 8(2):333-338.
96
Kroeger
KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on
the expression of the -308 tumour necrosis factor promoter polymorphism.
Cytokine 2000; 12(2):110-119.
97
Jenny
NS, Tracy RP, Ogg MS, Luong lA, Kuller LH, Arnold AM et al. In the elderly,
interleukin-6 plasma levels and the -174G>C polymorphism are associated
with the development of cardiovascular disease. Arterioscler Thromb Vasc
Biol 2002; 22(12):2066-2071.
98
Pedersen
M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E et al. Circulating
levels of TNF-alpha and IL-6 - Relation to truncal fat mass and muscle
mass in healthy elderly individuals and patients with type 2 diabetes.
Mech Ageing Dev 2003.
99
Bruunsgaard
H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. TNF-a, Leptin, and lymphocyte
function in human aging . Life Sci 2000; 67:2721-2731.
100
Straub
RH, Miller LE, Schölmerich J, Zietz B. Cytokines and hormones as possible
links between endocrinosenescence and immunosenescence. J Neuroimmunol
2000; 109:10-15.
101
Bruunsgaard
H, Østergaard L, Andersen-Ranberg K, Jeune B, Pedersen BK. Proinflammatory
cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases
in Danish centenarians - Is there a link? Scand J Infect Dis 2002; 34:493-499.
102
Priø
TK, Bruunsgaard H, Røge B, Skinhoj P, Pedersen BK. Asymtomatic bacteriuria
in elderly humans is associated with increased levels of circulating TNF
receptors. Experimental Gerontology 2002; 37(5):693-699.
103
Mocchegiani
E, Straub RA. Possible new anti aging strategies related to neuroendocrine
immune interactions. In “The neuroendocrine Immune Network in Ageing”,
Neuroimmune Biology Volume 4. Straub RH, Mocchegiani E. Eds., Berczi I,
Szentivasnyi A. Series Eds. Elsevier, Amsterdam, 2004 pp. (in this volume)
Any
questions, comments or problems with the website, please contact the web
site owner.